206 results on '"Peters, Anna"'
Search Results
202. Transfusion of 35-day stored red blood cells does not result in increase of plasma non-transferrin bound iron in human endotoxemia.
- Author
-
Peters AL, Kunanayagam RK, van Bruggen R, de Korte D, Juffermans NP, and Vlaar AP
- Subjects
- Adolescent, Adult, Bilirubin blood, Endotoxemia chemically induced, Ferritins blood, Haptoglobins metabolism, Hemoglobins metabolism, Humans, L-Lactate Dehydrogenase blood, Lipopolysaccharides toxicity, Male, Time Factors, Blood Preservation, Blood Transfusion, Autologous, Endotoxemia blood, Endotoxemia therapy, Erythrocyte Transfusion, Iron blood
- Abstract
Background: Transfusion of a single unit of stored red blood cells (RBCs) has been hypothesized to induce supra-physiological levels of non-transferrin bound iron (NTBI), which may enhance inflammation and act as a nutrient for bacteria. We investigated the relation between RBC storage time and iron levels in a clinically relevant "two-hit" human transfusion model., Study Design and Methods: Eighteen healthy male volunteers (ages 18-35 years) were infused with 2 ng lipopolysaccharide (LPS)/kg to induce systemic inflammatory response syndrome. Two hours later, each participant received either 1 unit of 2-day stored (2D) autologous RBCs, 35-day stored (35D) autologous RBCs, or an equal volume of saline. Every 2 hours up to 8 hours after LPS infusion, hemoglobin, hemolysis parameters, and iron parameters, including NTBI, were measured., Results: Transfusion of both 2D and 35D RBCs caused increases in hemoglobin, plasma iron, and transferrin saturation; whereas levels remained stable in the saline group. Transfusion of 35D RBCs did not result in hemolysis nor did it lead to increased levels of NTBI compared with 2D RBCs or saline. LPS induced increases in ferritin, haptoglobin, bilirubin, and lactate dehydrogenase that were similar in all three groups., Conclusion: We conclude that 35D autologous RBCs do not cause hemolysis or increased levels of NTBI during human endotoxemia., (© 2016 AABB.)
- Published
- 2017
- Full Text
- View/download PDF
203. Single Cell Cytochemistry Illustrated by the Demonstration of Glucose-6-Phosphate Dehydrogenase Deficiency in Erythrocytes.
- Author
-
Peters AL and van Noorden CJ
- Subjects
- Enzyme Activation, Genetic Testing methods, Glucosephosphate Dehydrogenase metabolism, Glucosephosphate Dehydrogenase Deficiency diagnosis, Humans, Oxidation-Reduction, Pentose Phosphate Pathway, Spectrophotometry, Erythrocytes metabolism, Glucosephosphate Dehydrogenase Deficiency enzymology, Glucosephosphate Dehydrogenase Deficiency genetics, Histocytochemistry methods, Single-Cell Analysis methods
- Abstract
Cytochemistry is the discipline that is applied to visualize specific molecules in individual cells and has become an essential tool in life sciences. Immunocytochemistry was developed in the sixties of last century and is the most frequently used cytochemical application. However, metabolic mapping is the oldest cytochemical approach to localize activity of specific enzymes, but in the last decades of the previous century and the first decade of the present century it almost became obsolete. The popularity of this approach revived in the past few years. Metabolism gained interest as player in chronic and complex diseases such as cancer, diabetes, neurodegenerative diseases, and vascular diseases and both enzyme cytochemistry and metabolic mapping have become important tools in life sciences.In this chapter, we present glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most prevalent enzyme deficiency worldwide, to illustrate recent developments in enzyme cytochemistry or metabolic mapping. The first assays which were developed quantified enzyme activity but were unreliable for single cell evaluation. The field has expanded with the development of cytochemical single cell assays and DNA testing. Still, all assays-from the earliest developed tests up to the most recently developed tests-have their place in investigations on G6PD activity. Recently, nanoscopy has become available for light and fluorescence microscopy at the nanoscale. For nanoscopy, cytochemistry is an essential tool to visualize intracellular molecular processes. The ultimate goal in the coming years will be nanoscopy of living cells so that the molecular dynamics can be studied. Cytochemistry will undoubtedly play a critical role in these developments.
- Published
- 2017
- Full Text
- View/download PDF
204. Clearance of stored red blood cells is not increased compared with fresh red blood cells in a human endotoxemia model.
- Author
-
Peters AL, Beuger B, Mock DM, Widness JA, de Korte D, Juffermans NP, Vlaar AP, and van Bruggen R
- Subjects
- Adolescent, Adult, Antigens, Surface metabolism, CD47 Antigen metabolism, Healthy Volunteers, Humans, Lipopolysaccharides, Male, Metabolic Clearance Rate, Milk Proteins metabolism, Netherlands, Phosphatidylserines metabolism, Young Adult, Blood Preservation, Endotoxemia etiology, Erythrocyte Transfusion adverse effects
- Abstract
Background: It is thought that the clearance of transfused red blood cells (RBCs) is related both to the storage time of the transfusion product and to the inflammatory status of the recipient. We investigated these effects in a randomized, "two-hit," healthy volunteer transfusion model, comparing autologous RBCs that were stored for 35 days with those that were stored for 2 days., Study Design and Methods: Healthy male volunteers donated 1 unit of autologous RBCs either 2 days (2D) or 35 days (35D) before the study date. The experiment was started by infusion of 2 ng/kg lipopolysaccharide ("first hit"). Two hours later, the stored RBCs ("second hit") were reinfused, followed by the labeling of RBCs with biotin. Clearance of biotin-labeled RBCs (BioRBCs) was measured during the 5-hour posttransfusion endotoxemia period along with measurements of phosphatidylserine (PS) exposure, lactadherin binding, and expression of CD47 (cluster of differentiation 47; a transmembrane protein encoded by the CD47 gene)., Results: In the 2D stored RBCs group, 1.5% ± 3.4% of infused BioRBCs were cleared from the circulation 5 hours posttransfusion versus 4.8% ± 4.0% in the 35D stored RBCs group (p = 0.1). There were no differences in PS exposure, lactadherin binding, or CD47 expression between fresh and stored RBCs or between pretransfusion and posttransfusion measurements., Conclusion: Our study shows a low clearance of RBCs even during endotoxemia. Furthermore, short-term clearance of BioRBCs during endotoxemia was not related to storage duration. Consistent with these observations, PS exposure, lactadherin binding, and CD47 expression did not differ between 2D and 35D stored cells before or after transfusion. We conclude that, in the presence of endotoxemia, clearance of 35D stored autologous RBCs is not increased compared with 2D stored fresh RBCs., (© 2016 AABB.)
- Published
- 2016
- Full Text
- View/download PDF
205. Pathogenesis of non-antibody mediated transfusion-related acute lung injury from bench to bedside.
- Author
-
Peters AL, van Hezel ME, Juffermans NP, and Vlaar AP
- Subjects
- Acute Lung Injury prevention & control, Acute Lung Injury therapy, Animals, Humans, Acute Lung Injury etiology, Transfusion Reaction, Translational Research, Biomedical
- Abstract
Transfusion-related acute lung injury (TRALI) is a major cause of transfusion-related mortality. Causative factors are divided in antibody mediated TRALI and non-antibody mediated TRALI. Antibody mediated TRALI is caused by passive transfusion of cognate antibodies and non-antibody mediated TRALI is caused by transfusion of aged cellular blood products. This review focuses on mechanisms in non-antibody mediated TRALI which includes soluble mediators accumulating during storage of red blood cells (RBCs) and platelets (PLTs), as well as changes in morphology and function of aged PLTs and RBCs. These mediators cause TRALI in two-hit animal models and have been implicated in TRALI onset in clinical studies. Pre-clinical studies show a clear relation between TRALI and increased storage time of cellular blood products. Observational clinical studies however report conflicting data. Knowledge of pathophysiological mechanisms of TRALI is necessary to improve storage conditions of blood products, develop prevention strategies and develop a therapy for TRALI., (Copyright © 2014 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
206. [Camphor poisoning following ingestion of mothballs 'for headache'].
- Author
-
Peters AL, Dekker E, and Michels WM
- Subjects
- Adult, Camphor therapeutic use, Female, Humans, Memory Disorders diagnosis, Memory Disorders etiology, Poison Control Centers, Poisoning complications, Poisoning therapy, Camphor poisoning, Emergency Medical Services, Headache drug therapy, Poisoning diagnosis
- Abstract
Background: Camphor is a toxic hydrocarbon, found in numerous over-the-counter medicinal products and chemist-shop items. The consequences of camphor poisoning depend on the dose, and severe poisoning can result in death. Ingestion of camphor can cause seizures, apnoea, renal insufficiency, raised hepatic enzyme levels, and vomiting resulting in chemical pneumonitis due to aspiration., Case Description: We present the case of a 34-year-old female patient from the Dominican Republic who was brought into our accident and emergency department following the ingestion of camphor mothballs for persisting headaches. She was unconscious (Glasgow coma score: 3) and had severe acidosis (pH 6.59), respiratory insufficiency, electrolyte imbalance and raised hepatic enzyme and amylase levels. She was admitted to the intensive care unit and recovered quickly. Five days later, she was transferred to a general ward, where it became apparent that she was suffering from severe memory loss. After eight days she was discharged in good clinical condition, although she still suffered some memory loss., Conclusion: Many every-day products contain camphor. Poisoning can lead to an acute clinical picture, and immediate intensive care department treatment is obligatory. As there is no antidote available, supportive care is the only available option when poisoning occurs.
- Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.